Qinghai Li

Qinghai Li

Auto-generated profile, based on publicly available information

Qinghai Li

Department of Respiratory and Critical Care Medicine, Qingdao Municipal Hospital, University of Health and Rehabilitation Sciences, Qingdao, 266071, People’s Republic of China

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2025 in Journal of Inflammation Research
Verified
Journal Article
Open access
PDF file
WHWenmin Hu
Wenmin Hu
JSJingjing Sun
Jingjing Sun
MWMei Wang
Mei Wang
YWYaoyao Wang
Yaoyao Wang
CMChaohui Mu
Chaohui Mu
QLQinghai Li
Qinghai Li
Background: Chronic obstructive pulmonary disease (COPD) pathogenesis involves persistent airway inflammation and remodeling, yet the role of anoikis resistance remains poorly characterized. This study aimed to identify anoikis resistance-related hub genes and evaluate their clinical utility in COPD phenotyping and prognosis. Methods: Integrated bioinformatics analysis of the GSE11906 dataset identified anoikis resistance-related differentially expressed genes (DEGs). Functional enrichment, LASSO regression, and machine learning (RF, SVM, XGB, GLM) were employed to pinpoint core hub genes. Multi-level validation included external datasets (GSE19407), in vitro (CSE-stimulated 16HBE cells), in vivo (cigarette smoke-exposed mice), and clinical samples (PBMCs). Diagnostic and prognostic models were developed using logistic regression. Results: Five core hub genes (UCHL1, ME1, SLC2A1, BMP4, CRABP2) were identified, with ME1, SLC2A1, and BMP4 consistently upregulated in COPD across models and strongly correlated with emphysema index (negative, R = − 0.41 to − 0.45) and airway wall thickness (positive, R = 0.40– 0.45). These genes exhibited significant associations with peribronchial immune cell infiltration. Diagnostic models for emphysema-predominant COPD (AUC = 0.860) and disease staging (AUC = 0.882), along with a prognostic model for hospitalization duration (AUC = 0.867), demonstrated robust clinical performance. Conclusion: ME1, SLC2A1, and BMP4 are pivotal anoikis resistance-related biomarkers in COPD, driving immune dysregulation and structural remodeling. The developed models enable precise phenotyping, severity stratification, and personalized prognosis prediction, advancing precision medicine strategies for COPD management.

1 March 2026 in International Journal of Chronic Obstructive Pulmonary Disease
Verified
Journal Article
Open access
PDF file
SQShuyi Qin
Shuyi Qin
XYXinjuan Yu
Xinjuan Yu
QMQianli Ma
Qianli Ma
LLLi Lin
Li Lin
QLQinghai Li
Qinghai Li
WHWei Han
Wei Han
Corrigendum for the article Quantitative CT Analysis of Small Airway Remodeling in Patients with Chronic Obstructive Pulmonary Disease by a New Image Post-Processing System